ACCOUNT

Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

PGe
NEWSLETTERS
PG STORE
ARCHIVES

CLASSIFIEDS

OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS

CONTACT US
ADVERTISING
CAREER OPPORTUNITIES

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

17.93 -1.17 (-6.13%)

Streaming Delayed Price Updated: 9:41 AM EDT, Jul 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

The Law Offices of Frank R. Cruz Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors

May 06, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors

May 06, 2021

From Law Offices of Howard G. Smith

Via Business Wire

ChemoCentryx Investors With Losses Greater Than $100,000 - Kehoe Law Firm, P.C. Securities Class Action Investigation

May 06, 2021

Class Action Investigation On Behalf Of ChemoCentryx Investors With Significant Losses

Via EIN Presswire

Topics Fraud Lawsuit

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

May 06, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm

May 06, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CCXI

May 06, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

May 05, 2021

From The Schall Law Firm

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 05, 2021

Gainers Chiasma (NASDAQ:CHMA) stock moved upwards by 39.04% to $3.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $228.4...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 05, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

May 04, 2021

From The Schall Law Firm

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 04, 2021

Gainers Obalon Therapeutics (NASDAQ:OBLN)...

Via Benzinga

Why ChemoCentryx Stock Crashed Today ↗

May 04, 2021

The FDA's briefing documents for an advisory committee don't appear to bode well for avacopan's chances of approval.

Via The Motley Fool

Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today ↗

May 04, 2021

Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc. (NASDAQ: STIM) and BioLineRx Ltd. (NASDAQ: BLRX) are among the biggest health care...

Via Benzinga

Dow Stares at Triple-Digit Landslide While Tech Takes a Hit ↗

May 04, 2021

The Nasdaq is down more than 2% this afternoon as FAANG stocks weigh.

Via Talk Markets

Topics Stocks

ChemoCentryx Stock Plunges As FDA Briefing Document Casts Doubt On Vasculitis Candidate Avacopan's Data ↗

May 04, 2021

ChemoCentryx Inc (NASDAQ: CCXI) shares plunged after an FDA briefing document indicates the agency has “several areas of concerns” with its vasculitis...

Via Benzinga

Why ChemoCentryx's Stock Is Plunging Today ↗

May 04, 2021

ChemoCentryx, Inc. (NASDAQ: CCXI) shares are trading lower after FDA briefing documents for avacopan identified areas of concern, which raised "uncertainties about the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 04, 2021

Gainers Cocrystal Pharma (NASDAQ:COCP) stock rose 143.41% to $3.02 during Tuesday's regular session. Trading volume for Cocrystal Pharma's stock is 378.0 million...

Via Benzinga

44 Stocks Moving In Tuesday's Mid-Day Session ↗

May 04, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Pfizer Raises FY21 Outlook ↗

May 04, 2021

Following the market opening Tuesday, the Dow traded down 0.58% to 33,914.95 while the NASDAQ fell 1.94% to 13,625.24. The S&P also fell, dropping 0.95% to 4,152.79. The U.S....

Via Benzinga

Topics Stocks

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

ChemoCentryx Inc (CCXI) Q1 2021 Earnings Call Transcript ↗

April 30, 2021

CCXI earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Recap: ChemoCentryx Q1 Earnings ↗

April 29, 2021

Shares of ChemoCentryx (NASDAQ:CCXI) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 22.86% over the past...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 21, 2021

Wednesday morning, 25 companies reached new 52-week lows. Intriguing Points: Lufax Holding (NYSE:LU) was the biggest company by market cap to set a new 52-week low...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.